News
When it comes to the value of human life, there can be no ambiguity, no compromise, and no room for radical abortion extremists ...
Replimune Group's RP1 oncolytic virus therapy faced an FDA rejection, raising concerns about the platform's viability in ...
One great example of a “what the hell is happening here” story run just the other day that opened with, “Orange juice, known ...
New evidence of effectiveness is cause to drop a Biden restriction on Medicare coverage for anti-amyloid treatments.
The HHS secretary is targeting a liability shield for destruction.
Sarepta Therapeutics (NASDAQ:SRPT) has hired a lobbying firm with close ties to the Trump administration as regulatory ...
U.S. Defense Secretary Pete Hegseth announced Tuesday that a Confederate memorial would be reinstalled in Arlington Cemetery ...
Dr Vinay Prasad was asked to step down as the FDA's top vaccine official following several controversies during his brief tenure.
The Trump administration has been in a tailspin over the case files since the beginning of July, when the Justice Department ...
George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...
Trump appeared to acknowledge in the interview that his ruthless mass deportation campaign is hurting farms, which rely on ...
2d
MedPage Today on MSNCDC Funds Frozen; Prasad Didn't Reject Replimune; Filling the Gender Care GapThe Trump administration blocked funding for a number of CDC public health programs, the Wall Street Journal reported. Programs that would not be fully funded under the freeze include those focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results